Intestinal epithelial HDAC3 and MHC class II coordinate microbiota-specific immunity

Area of Science:

• Immunology
• Microbiology
• Gastroenterology

Background:

• Aberrant immune responses to gut microbes drive inflammatory bowel disease.
• Control mechanisms for microbiota-specific immunity in mucosal tissues are not well understood.

Purpose of the Study:

• To investigate the role of epithelial histone deacetylase 3 (HDAC3) in instructing microbiota-specific immunity.
• To understand how epithelial HDAC3 influences CD4+ T cell populations and intestinal inflammation.

Main Methods:

• Mice lacking epithelial HDAC3 were used to study microbiota-specific immunity.
• Analysis of CD4+ T cell subsets (Tregs, Th17) and epithelial MHC class II (MHCII) expression.
• Investigated the NF-κB signaling pathway's role in HDAC3-mediated MHCII regulation.

Main Results:

• Epithelial HDAC3 deficiency led to increased commensal-specific CD4+ T cells in the intestine.
• Loss of epithelial HDAC3 decreased regulatory T cells (Tregs) and increased Th17 cells, promoting colitis.
• HDAC3 is crucial for NF-κB-dependent epithelial MHCII expression, which limits Th17 cells and protects against inflammation.

Conclusions:

• Epithelial HDAC3 plays a critical role in balancing microbiota-specific CD4+ T cell subsets in the intestine.
• HDAC3-mediated regulation of epithelial MHCII is essential for controlling T cell responses to commensal microbes.
• These findings reveal a novel mechanism by which epithelial cells shape mucosal immunity and prevent chronic inflammation.